CorMedix Inc. (NASDAQ:CRMD) Receives Average Rating of “Buy” from Analysts
Shares of CorMedix Inc. (NASDAQ:CRMD – Get Free Report) have earned a consensus rating of “Buy” from the eight ratings firms that are covering the company, Marketbeat reports. Seven equities research analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1-year price […]
Shares of CorMedix Inc. (NASDAQ:CRMD – Get Free Report) have earned a consensus rating of “Buy” from the eight ratings firms that are covering the company, Marketbeat reports. Seven equities research analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1-year price […]
